Skip to main content
Caplight Logo









HeliXon

HeliXon

Private
BeijingHealthcare & Life Scienceshttps://www.helixon.com/

Last Round

Series A

Jun 22, 2022

Total Funding Raised

$74.8M

Company Overview

HeliXon is a biotechnology company that develops an artificial intelligence platform for scientific computing to enhance the efficiency of medical research and drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoveryAI drug discoveryprotein engineeringgenerative protein designantibody therapeuticsin silico drug discoverybiologicsbispecific antibodieshigh-throughput screeningstructure predictioncomputational biologypharma R&DAI-native biotechdrug design platformprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HeliXon Comparables

Compare HeliXon with similar companies based on industry and business-model similarity.

HeliXon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharMolix
83%
Nabla
83%
Chai Discovery
81%

HeliXon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2022
AngelOct 1, 2021

HeliXon Investors

Notable investors and investment history

HeliXon investors
InvestorRounds
Hillhouse InvestmentSeries A, Angel
Neumann AdvisorsSeries A
Neumann CapitalSeries A
5Y CapitalSeries A
GL VenturesSeries A
Tsinghua CapitalAngel
Xiang He CapitalSeries A, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 64% MoM.

  • Jun 22, 2022

    $75M round led by 5Y Capital and Morningside.

HeliXon Filings

Explore SEC and related filing metadata, where available.

HeliXon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HeliXon's valuation, stock price, and market status.

Is HeliXon a public or private company?

HeliXon is a private company.

What is the current stock price of HeliXon?

HeliXon is a private company with no public stock price. No recent secondary market data is available.

How much is HeliXon worth (valuation)?

Valuation information for HeliXon is not publicly available.

Can I buy HeliXon stock?

HeliXon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HeliXon's last funding round?

HeliXon's most recent funding round was Series A on June 22, 2022.

Who are the main investors in HeliXon?

Key investors in HeliXon include 5Y Capital.

Will HeliXon IPO soon?

No public IPO plans have been announced for HeliXon.

How can I track HeliXon secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HeliXon's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range11
Year Founded2021
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?